|
Product Details:
|
| Model: | 25MG | Name: | Pharmaceutical Tablets |
|---|---|---|---|
| Type: | Cardiovascular Naftopidil Tablets | Certification: | GMP |
| Origin: | ANHUI | Brand: | BBCA |
| High Light: | tablet shapes pharmaceutical,metronidazole tablets |
||
Pharmaceutical Tablets Cardiovascular Naftopidil Tablets
[INDICATIONS]
It is used to relieve the symptoms of urinary obstruction caused by benign prostatic hyperplasia (BPH).
[USAGE AND DOSAGE]
Oral. Usually, the initial dosage of adult is 25mg (1 tablets), once a day, taken before bedtime. The dose can be adjusted appropriately with the clinical effect. The maximum dose may not exceed 75mg (3 tablets) per day. Elderly patients should start from low dose (12.5mg/day), and care for them.
[ADVERSE REACTION]
dizziness, standing vertigo, head weight, headache, tinnitus, constipation, stomach discomfort, edema, chills, AST elevation and ALT elevation.
[CONTRAINDICATION]
It is forbidden for someone has a history of allergy .
[DRUG INTERACTION]
This product has synergistic antihypertensive effect with the combination of diuretics and antihypertensive drugs, and should be reduced when combined.
[DRUG OVERDOSE]
There are no reports of overdose of the drug at present. If you take too much, you should take symptomatic treatment.
Contact Person: Eric
Tel: +86-551-64846195
